In order to investigate the possibility of turning Bmi-1 into a novel therapeutic agent for the treatment of breast cancer, MCF-7 was chosen to silence the expression of Bmi-1 with the highly specific post-transcriptional suppression of RNAi. Here, BMI1 is linked to breast cancer.